Clinical Trial Detail

NCT ID	NCT03598608
Title	Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Merck Sharp & Dohme Corp.
Indications	non-Hodgkin lymphoma diffuse large B-cell lymphoma Hodgkin's lymphoma
Therapies	MK-4280 + Pembrolizumab
Age Groups:	adult \| senior
Covered Countries	USA \| ITA \| ISR \| DEU \| CAN \| AUS

Filter rows:

Showing 1 to 25 of 25 entries

Facility	City	State	Zip	Country	Details
A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 0351)	Bologna	Emilia-Romagna	40138	Italy	Details
Banner MD Anderson Cancer Center ( Site 0020)	Gilbert	Arizona	85234	United States	Details
BC Cancer ( Site 0107)	Vancouver	British Columbia	V5Z 1L3	Canada	Details
CancerCare Manitoba ( Site 0101)	Winnipeg	Manitoba	R3E 0V9	Canada	Details
Chaim Sheba Medical Center. ( Site 0380)	Ramat Gan		5262001	Israel	Details
City of Hope ( Site 0001)	Duarte	California	91010	United States	Details
Concord Repatriation & General Hospital ( Site 0203)	Concord	New South Wales	2139	Australia	Details
Dana Farber Cancer Institute ( Site 0002)	Boston	Massachusetts	02215	United States	Details
Fox Chase Cancer Center ( Site 0019)	Philadelphia	Pennsylvania	19111	United States	Details
Hadassah Ein Karem Jerusalem ( Site 0383)	Jerusalem		9112001	Israel	Details
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 0352)	Rozzano	Milano	20089	Italy	Details
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ( Site 0354)	Meldola	Forli-Cesena	47014	Italy	Details
Jewish General Hospital ( Site 0105)	Montreal	Quebec	H3T 1E2	Canada	Details
Monash Health ( Site 0201)	Clayton	Victoria	3168	Australia	Details
Pacific Cancer Care ( Site 0006)	Monterey	California	93940	United States	Details
Princess Alexandra Hospital ( Site 0204)	Woollongabba	Queensland	4102	Australia	Details
Princess Margaret Cancer Centre ( Site 0100)	Toronto	Ontario	M5G 2M9	Canada	Details
Rambam Medical Center ( Site 0382)	Haifa		3109601	Israel	Details
Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007)	Los Angeles	California	90095	United States	Details
Sourasky Medical Center ( Site 0381)	Tel Aviv		6423906	Israel	Details
St Vincent s Hospital (Melbourne) Limited ( Site 0202)	Fitzroy	Victoria	3065	Australia	Details
Texas Oncology-Austin Midtown ( Site 8002)	Austin	Texas	78705	United States	Details
U. klinikum Koeln AOER ( Site 0326)	Koeln	Nordrhein-Westfalen	50937	Germany	Details
Universitaetsklinikum Leipzig AOeR ( Site 0327)	Leipzig	Sachsen	4103	Germany	Details
University of California San Francisco ( Site 0023)	San Francisco	California	94143	United States	Details

Showing 1 to 25 of 25 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

Clinical Trial Detail

Contact